Abeona Therapeutics (ABEO) Misses Q3 EPS by 1c

Abeona Therapeutics (NASDAQ: ABEO) reported Q3 EPS of ($1.48), $0.01 worse than the analyst estimate of ($1.47).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• GameStop posts higher income despite revenue drop in Q2 2026
• Argus Upgrades Abercrombie & Fitch (ANF) to Buy